デフォルト表紙
市場調査レポート
商品コード
1090513

世界の固形製剤 ドラッグデリバリー市場:考察と予測 (2028年まで)

Global Solid Formulations Drug Delivery Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 113 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
世界の固形製剤 ドラッグデリバリー市場:考察と予測 (2028年まで)
出版日: 2022年06月17日
発行: QYResearch
ページ情報: 英文 113 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、固形製剤 ドラッグデリバリー (Solid Formulations Drug Delivery) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の固形製剤 ドラッグデリバリーの市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Powders
    • Suppositories
  • 市場:アプリケーション別
    • 世界の固形製剤 ドラッグデリバリーの市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Home Care Settings
    • Hospitals & Clinics
    • Burn Centers
    • Other Facilities
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の固形製剤 ドラッグデリバリーの市場展望 (2017-2028)
  • 固形製剤 ドラッグデリバリーの市場成長トレンド:地域別
    • 固形製剤 ドラッグデリバリー 市場規模:地域別: 2017 VS 2021 VS 2028
    • 固形製剤 ドラッグデリバリーの市場規模実績:地域別 (2017-2022)
    • 固形製剤 ドラッグデリバリーの市場規模予測:地域別 (2023-2028)
  • 固形製剤 ドラッグデリバリー 市場動向
    • 固形製剤 ドラッグデリバリー 業界動向
    • 固形製剤 ドラッグデリバリー 市場の促進要因
    • 固形製剤 ドラッグデリバリー 市場の課題
    • 固形製剤 ドラッグデリバリー 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界の固形製剤 ドラッグデリバリーの上位企業:収益別
    • 世界の固形製剤 ドラッグデリバリーの上位企業:収益別 (2017-2022)
    • 世界の固形製剤 ドラッグデリバリーの収益シェア:企業別 (2017-2022)
  • 世界の固形製剤 ドラッグデリバリーの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:固形製剤 ドラッグデリバリーの収益
  • 世界の固形製剤 ドラッグデリバリー 市場集中度
    • 世界の固形製剤 ドラッグデリバリー 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 固形製剤 ドラッグデリバリーの収益 2021
  • 固形製剤 ドラッグデリバリーの主要企業の本社および事業エリア
  • 主要企業 固形製剤 ドラッグデリバリーの製品ソリューションおよびサービス
  • 市場参入時期: 固形製剤 ドラッグデリバリー 市場
  • M&A, 拡張計画

第4章 固形製剤 ドラッグデリバリー 内訳データ:タイプ別

  • 世界の固形製剤 ドラッグデリバリーの市場規模実績:タイプ別 (2017-2022)
  • 世界の固形製剤 ドラッグデリバリーの市場規模予測:タイプ別 (2023-2028)

第5章 固形製剤 ドラッグデリバリー 内訳データ:アプリケーション別

  • 世界の固形製剤 ドラッグデリバリーの市場規模実績:アプリケーション別 (2017-2022)
  • 世界の固形製剤 ドラッグデリバリーの市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米の固形製剤 ドラッグデリバリー 市場規模 (2017-2028)
  • 北米の固形製剤 ドラッグデリバリー 市場規模:タイプ別
    • 北米の固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2017-2022)
    • 北米の固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2023-2028)
    • 北米の固形製剤 ドラッグデリバリーの市場シェア:タイプ別 (2017-2028)
  • 北米の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別
    • 北米の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2017-2022)
    • 北米の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2023-2028)
    • 北米の固形製剤 ドラッグデリバリーの市場シェア:アプリケーション別 (2017-2028)
  • 北米の固形製剤 ドラッグデリバリー 市場規模:国別
    • 北米の固形製剤 ドラッグデリバリー 市場規模:国別 (2017-2022)
    • 北米の固形製剤 ドラッグデリバリー 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の固形製剤 ドラッグデリバリー 市場規模 (2017-2028)
  • 欧州の固形製剤 ドラッグデリバリー 市場規模:タイプ別
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2017-2022)
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2023-2028)
    • 欧州の固形製剤 ドラッグデリバリーの市場シェア:タイプ別 (2017-2028)
  • 欧州の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2017-2022)
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2023-2028)
    • 欧州の固形製剤 ドラッグデリバリーの市場シェア:アプリケーション別 (2017-2028)
  • 欧州の固形製剤 ドラッグデリバリー 市場規模:国別
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:国別 (2017-2022)
    • 欧州の固形製剤 ドラッグデリバリー 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模 (2017-2028)
  • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:タイプ別
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 固形製剤 ドラッグデリバリーの市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:アプリケーション別
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 固形製剤 ドラッグデリバリーの市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:地域別
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 固形製剤 ドラッグデリバリー 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模 (2017-2028)
  • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカの固形製剤 ドラッグデリバリーの市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカの固形製剤 ドラッグデリバリーの市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:国別
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:国別 (2017-2022)
    • ラテンアメリカの固形製剤 ドラッグデリバリー 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模 (2017-2028)
  • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカの固形製剤 ドラッグデリバリーの市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカの固形製剤 ドラッグデリバリーの市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:国別
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:国別 (2017-2022)
    • 中東・アフリカの固形製剤 ドラッグデリバリー 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Pfizer
  • Teva Pharmaceuticals
  • Bristol Myers Squibb
  • Lead Chemical
  • Purdue Pharma
  • Glenmark Pharmaceuticals
  • Galderma
  • Johnson & Johnson Private
  • GlaxoSmithKline
  • Bausch Health Companies
  • Hisamitsu Pharmaceuticals
  • Cipla
  • Bayer
  • Viatris
  • 3M
  • Merck & Co
  • Crescita Therpeautics
  • Novartis International
  • Boehringer Ingelheim

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Solid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Powders
  • Table 3. Key Players of Suppositories
  • Table 4. Global Solid Formulations Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Solid Formulations Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Solid Formulations Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Solid Formulations Drug Delivery Market Share by Region (2017-2022)
  • Table 8. Global Solid Formulations Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Solid Formulations Drug Delivery Market Share by Region (2023-2028)
  • Table 10. Solid Formulations Drug Delivery Market Trends
  • Table 11. Solid Formulations Drug Delivery Market Drivers
  • Table 12. Solid Formulations Drug Delivery Market Challenges
  • Table 13. Solid Formulations Drug Delivery Market Restraints
  • Table 14. Global Solid Formulations Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Solid Formulations Drug Delivery Revenue Share by Players (2017-2022)
  • Table 16. Global Top Solid Formulations Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Formulations Drug Delivery as of 2021)
  • Table 17. Ranking of Global Top Solid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Solid Formulations Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Solid Formulations Drug Delivery Product Solution and Service
  • Table 21. Date of Enter into Solid Formulations Drug Delivery Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Solid Formulations Drug Delivery Revenue Market Share by Type (2017-2022)
  • Table 25. Global Solid Formulations Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Solid Formulations Drug Delivery Revenue Market Share by Type (2023-2028)
  • Table 27. Global Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Solid Formulations Drug Delivery Revenue Share by Application (2017-2022)
  • Table 29. Global Solid Formulations Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Solid Formulations Drug Delivery Revenue Share by Application (2023-2028)
  • Table 31. North America Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Solid Formulations Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Solid Formulations Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Solid Formulations Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Solid Formulations Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Solid Formulations Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Solid Formulations Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Solid Formulations Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Solid Formulations Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Solid Formulations Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Solid Formulations Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Solid Formulations Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Solid Formulations Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Solid Formulations Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Solid Formulations Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Solid Formulations Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Solid Formulations Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Pfizer Company Details
  • Table 62. Pfizer Business Overview
  • Table 63. Pfizer Solid Formulations Drug Delivery Product
  • Table 64. Pfizer Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 65. Pfizer Recent Developments
  • Table 66. Teva Pharmaceuticals Company Details
  • Table 67. Teva Pharmaceuticals Business Overview
  • Table 68. Teva Pharmaceuticals Solid Formulations Drug Delivery Product
  • Table 69. Teva Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 70. Teva Pharmaceuticals Recent Developments
  • Table 71. Bristol Myers Squibb Company Details
  • Table 72. Bristol Myers Squibb Business Overview
  • Table 73. Bristol Myers Squibb Solid Formulations Drug Delivery Product
  • Table 74. Bristol Myers Squibb Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 75. Bristol Myers Squibb Recent Developments
  • Table 76. Lead Chemical Company Details
  • Table 77. Lead Chemical Business Overview
  • Table 78. Lead Chemical Solid Formulations Drug Delivery Product
  • Table 79. Lead Chemical Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 80. Lead Chemical Recent Developments
  • Table 81. Purdue Pharma Company Details
  • Table 82. Purdue Pharma Business Overview
  • Table 83. Purdue Pharma Solid Formulations Drug Delivery Product
  • Table 84. Purdue Pharma Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 85. Purdue Pharma Recent Developments
  • Table 86. Glenmark Pharmaceuticals Company Details
  • Table 87. Glenmark Pharmaceuticals Business Overview
  • Table 88. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Product
  • Table 89. Glenmark Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 90. Glenmark Pharmaceuticals Recent Developments
  • Table 91. Galderma Company Details
  • Table 92. Galderma Business Overview
  • Table 93. Galderma Solid Formulations Drug Delivery Product
  • Table 94. Galderma Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 95. Galderma Recent Developments
  • Table 96. Johnson & Johnson Private Company Details
  • Table 97. Johnson & Johnson Private Business Overview
  • Table 98. Johnson & Johnson Private Solid Formulations Drug Delivery Product
  • Table 99. Johnson & Johnson Private Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 100. Johnson & Johnson Private Recent Developments
  • Table 101. GlaxoSmithKline Company Details
  • Table 102. GlaxoSmithKline Business Overview
  • Table 103. GlaxoSmithKline Solid Formulations Drug Delivery Product
  • Table 104. GlaxoSmithKline Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 105. GlaxoSmithKline Recent Developments
  • Table 106. Bausch Health Companies Company Details
  • Table 107. Bausch Health Companies Business Overview
  • Table 108. Bausch Health Companies Solid Formulations Drug Delivery Product
  • Table 109. Bausch Health Companies Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 110. Bausch Health Companies Recent Developments
  • Table 111. Hisamitsu Pharmaceuticals Company Details
  • Table 112. Hisamitsu Pharmaceuticals Business Overview
  • Table 113. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Product
  • Table 114. Hisamitsu Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 115. Hisamitsu Pharmaceuticals Recent Developments
  • Table 116. Cipla Company Details
  • Table 117. Cipla Business Overview
  • Table 118. Cipla Solid Formulations Drug Delivery Product
  • Table 119. Cipla Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 120. Cipla Recent Developments
  • Table 121. Bayer Company Details
  • Table 122. Bayer Business Overview
  • Table 123. Bayer Solid Formulations Drug Delivery Product
  • Table 124. Bayer Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 125. Bayer Recent Developments
  • Table 126. Viatris Company Details
  • Table 127. Viatris Business Overview
  • Table 128. Viatris Solid Formulations Drug Delivery Product
  • Table 129. Viatris Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 130. Viatris Recent Developments
  • Table 131. 3M Company Details
  • Table 132. 3M Business Overview
  • Table 133. 3M Solid Formulations Drug Delivery Product
  • Table 134. 3M Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 135. 3M Recent Developments
  • Table 136. Merck & Co Company Details
  • Table 137. Merck & Co Business Overview
  • Table 138. Merck & Co Solid Formulations Drug Delivery Product
  • Table 139. Merck & Co Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 140. Merck & Co Recent Developments
  • Table 141. Crescita Therpeautics Company Details
  • Table 142. Crescita Therpeautics Business Overview
  • Table 143. Crescita Therpeautics Solid Formulations Drug Delivery Product
  • Table 144. Crescita Therpeautics Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 145. Crescita Therpeautics Recent Developments
  • Table 146. Novartis International Company Details
  • Table 147. Novartis International Business Overview
  • Table 148. Novartis International Solid Formulations Drug Delivery Product
  • Table 149. Novartis International Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 150. Novartis International Recent Developments
  • Table 151. Boehringer Ingelheim Company Details
  • Table 152. Boehringer Ingelheim Business Overview
  • Table 153. Boehringer Ingelheim Solid Formulations Drug Delivery Product
  • Table 154. Boehringer Ingelheim Revenue in Solid Formulations Drug Delivery Business (2017-2022) & (US$ Million)
  • Table 155. Boehringer Ingelheim Recent Developments
  • Table 156. Research Programs/Design for This Report
  • Table 157. Key Data Information from Secondary Sources
  • Table 158. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Solid Formulations Drug Delivery Market Share by Type: 2021 VS 2028
  • Figure 2. Powders Features
  • Figure 3. Suppositories Features
  • Figure 4. Global Solid Formulations Drug Delivery Market Share by Application: 2021 VS 2028
  • Figure 5. Home Care Settings Case Studies
  • Figure 6. Hospitals & Clinics Case Studies
  • Figure 7. Burn Centers Case Studies
  • Figure 8. Other Facilities Case Studies
  • Figure 9. Solid Formulations Drug Delivery Report Years Considered
  • Figure 10. Global Solid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Solid Formulations Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Solid Formulations Drug Delivery Market Share by Region: 2021 VS 2028
  • Figure 13. Global Solid Formulations Drug Delivery Market Share by Players in 2021
  • Figure 14. Global Top Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Formulations Drug Delivery as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Solid Formulations Drug Delivery Revenue in 2021
  • Figure 16. North America Solid Formulations Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Solid Formulations Drug Delivery Market Size Share by Country (2017-2028)
  • Figure 20. United States Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Solid Formulations Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Solid Formulations Drug Delivery Market Size Share by Country (2017-2028)
  • Figure 26. Germany Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Solid Formulations Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Solid Formulations Drug Delivery Market Size Share by Region (2017-2028)
  • Figure 36. China Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Solid Formulations Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Solid Formulations Drug Delivery Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Solid Formulations Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Solid Formulations Drug Delivery Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Solid Formulations Drug Delivery Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Solid Formulations Drug Delivery Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Solid Formulations Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Pfizer Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 57. Bristol Myers Squibb Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 58. Lead Chemical Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 59. Purdue Pharma Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 60. Glenmark Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 61. Galderma Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 62. Johnson & Johnson Private Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 63. GlaxoSmithKline Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 64. Bausch Health Companies Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 65. Hisamitsu Pharmaceuticals Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 66. Cipla Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 67. Bayer Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 68. Viatris Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 69. 3M Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 70. Merck & Co Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 71. Crescita Therpeautics Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 72. Novartis International Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 73. Boehringer Ingelheim Revenue Growth Rate in Solid Formulations Drug Delivery Business (2017-2022)
  • Figure 74. Bottom-up and Top-down Approaches for This Report
  • Figure 75. Data Triangulation
  • Figure 76. Key Executives Interviewed
目次

This research report focuses on the Solid Formulations Drug Delivery Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Solid Formulations Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Powders
    • 1.2.3 Suppositories
  • 1.3 Market by Application
    • 1.3.1 Global Solid Formulations Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Home Care Settings
    • 1.3.3 Hospitals & Clinics
    • 1.3.4 Burn Centers
    • 1.3.5 Other Facilities
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Solid Formulations Drug Delivery Market Perspective (2017-2028)
  • 2.2 Solid Formulations Drug Delivery Growth Trends by Region
    • 2.2.1 Solid Formulations Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Solid Formulations Drug Delivery Historic Market Size by Region (2017-2022)
    • 2.2.3 Solid Formulations Drug Delivery Forecasted Market Size by Region (2023-2028)
  • 2.3 Solid Formulations Drug Delivery Market Dynamics
    • 2.3.1 Solid Formulations Drug Delivery Industry Trends
    • 2.3.2 Solid Formulations Drug Delivery Market Drivers
    • 2.3.3 Solid Formulations Drug Delivery Market Challenges
    • 2.3.4 Solid Formulations Drug Delivery Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Solid Formulations Drug Delivery Players by Revenue
    • 3.1.1 Global Top Solid Formulations Drug Delivery Players by Revenue (2017-2022)
    • 3.1.2 Global Solid Formulations Drug Delivery Revenue Market Share by Players (2017-2022)
  • 3.2 Global Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Solid Formulations Drug Delivery Revenue
  • 3.4 Global Solid Formulations Drug Delivery Market Concentration Ratio
    • 3.4.1 Global Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Solid Formulations Drug Delivery Revenue in 2021
  • 3.5 Solid Formulations Drug Delivery Key Players Head office and Area Served
  • 3.6 Key Players Solid Formulations Drug Delivery Product Solution and Service
  • 3.7 Date of Enter into Solid Formulations Drug Delivery Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Solid Formulations Drug Delivery Breakdown Data by Type

  • 4.1 Global Solid Formulations Drug Delivery Historic Market Size by Type (2017-2022)
  • 4.2 Global Solid Formulations Drug Delivery Forecasted Market Size by Type (2023-2028)

5 Solid Formulations Drug Delivery Breakdown Data by Application

  • 5.1 Global Solid Formulations Drug Delivery Historic Market Size by Application (2017-2022)
  • 5.2 Global Solid Formulations Drug Delivery Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Solid Formulations Drug Delivery Market Size (2017-2028)
  • 6.2 North America Solid Formulations Drug Delivery Market Size by Type
    • 6.2.1 North America Solid Formulations Drug Delivery Market Size by Type (2017-2022)
    • 6.2.2 North America Solid Formulations Drug Delivery Market Size by Type (2023-2028)
    • 6.2.3 North America Solid Formulations Drug Delivery Market Share by Type (2017-2028)
  • 6.3 North America Solid Formulations Drug Delivery Market Size by Application
    • 6.3.1 North America Solid Formulations Drug Delivery Market Size by Application (2017-2022)
    • 6.3.2 North America Solid Formulations Drug Delivery Market Size by Application (2023-2028)
    • 6.3.3 North America Solid Formulations Drug Delivery Market Share by Application (2017-2028)
  • 6.4 North America Solid Formulations Drug Delivery Market Size by Country
    • 6.4.1 North America Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    • 6.4.2 North America Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Solid Formulations Drug Delivery Market Size (2017-2028)
  • 7.2 Europe Solid Formulations Drug Delivery Market Size by Type
    • 7.2.1 Europe Solid Formulations Drug Delivery Market Size by Type (2017-2022)
    • 7.2.2 Europe Solid Formulations Drug Delivery Market Size by Type (2023-2028)
    • 7.2.3 Europe Solid Formulations Drug Delivery Market Share by Type (2017-2028)
  • 7.3 Europe Solid Formulations Drug Delivery Market Size by Application
    • 7.3.1 Europe Solid Formulations Drug Delivery Market Size by Application (2017-2022)
    • 7.3.2 Europe Solid Formulations Drug Delivery Market Size by Application (2023-2028)
    • 7.3.3 Europe Solid Formulations Drug Delivery Market Share by Application (2017-2028)
  • 7.4 Europe Solid Formulations Drug Delivery Market Size by Country
    • 7.4.1 Europe Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    • 7.4.2 Europe Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Solid Formulations Drug Delivery Market Size (2017-2028)
  • 8.2 Asia-Pacific Solid Formulations Drug Delivery Market Size by Type
    • 8.2.1 Asia-Pacific Solid Formulations Drug Delivery Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Solid Formulations Drug Delivery Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Solid Formulations Drug Delivery Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Solid Formulations Drug Delivery Market Size by Application
    • 8.3.1 Asia-Pacific Solid Formulations Drug Delivery Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Solid Formulations Drug Delivery Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Solid Formulations Drug Delivery Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region
    • 8.4.1 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Solid Formulations Drug Delivery Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Solid Formulations Drug Delivery Market Size (2017-2028)
  • 9.2 Latin America Solid Formulations Drug Delivery Market Size by Type
    • 9.2.1 Latin America Solid Formulations Drug Delivery Market Size by Type (2017-2022)
    • 9.2.2 Latin America Solid Formulations Drug Delivery Market Size by Type (2023-2028)
    • 9.2.3 Latin America Solid Formulations Drug Delivery Market Share by Type (2017-2028)
  • 9.3 Latin America Solid Formulations Drug Delivery Market Size by Application
    • 9.3.1 Latin America Solid Formulations Drug Delivery Market Size by Application (2017-2022)
    • 9.3.2 Latin America Solid Formulations Drug Delivery Market Size by Application (2023-2028)
    • 9.3.3 Latin America Solid Formulations Drug Delivery Market Share by Application (2017-2028)
  • 9.4 Latin America Solid Formulations Drug Delivery Market Size by Country
    • 9.4.1 Latin America Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    • 9.4.2 Latin America Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Solid Formulations Drug Delivery Market Size (2017-2028)
  • 10.2 Middle East & Africa Solid Formulations Drug Delivery Market Size by Type
    • 10.2.1 Middle East & Africa Solid Formulations Drug Delivery Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Solid Formulations Drug Delivery Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Solid Formulations Drug Delivery Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Solid Formulations Drug Delivery Market Size by Application
    • 10.3.1 Middle East & Africa Solid Formulations Drug Delivery Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Solid Formulations Drug Delivery Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Solid Formulations Drug Delivery Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country
    • 10.4.1 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Solid Formulations Drug Delivery Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Solid Formulations Drug Delivery Introduction
    • 11.1.4 Pfizer Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.1.5 Pfizer Recent Developments
  • 11.2 Teva Pharmaceuticals
    • 11.2.1 Teva Pharmaceuticals Company Details
    • 11.2.2 Teva Pharmaceuticals Business Overview
    • 11.2.3 Teva Pharmaceuticals Solid Formulations Drug Delivery Introduction
    • 11.2.4 Teva Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.2.5 Teva Pharmaceuticals Recent Developments
  • 11.3 Bristol Myers Squibb
    • 11.3.1 Bristol Myers Squibb Company Details
    • 11.3.2 Bristol Myers Squibb Business Overview
    • 11.3.3 Bristol Myers Squibb Solid Formulations Drug Delivery Introduction
    • 11.3.4 Bristol Myers Squibb Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.3.5 Bristol Myers Squibb Recent Developments
  • 11.4 Lead Chemical
    • 11.4.1 Lead Chemical Company Details
    • 11.4.2 Lead Chemical Business Overview
    • 11.4.3 Lead Chemical Solid Formulations Drug Delivery Introduction
    • 11.4.4 Lead Chemical Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.4.5 Lead Chemical Recent Developments
  • 11.5 Purdue Pharma
    • 11.5.1 Purdue Pharma Company Details
    • 11.5.2 Purdue Pharma Business Overview
    • 11.5.3 Purdue Pharma Solid Formulations Drug Delivery Introduction
    • 11.5.4 Purdue Pharma Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.5.5 Purdue Pharma Recent Developments
  • 11.6 Glenmark Pharmaceuticals
    • 11.6.1 Glenmark Pharmaceuticals Company Details
    • 11.6.2 Glenmark Pharmaceuticals Business Overview
    • 11.6.3 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Introduction
    • 11.6.4 Glenmark Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.6.5 Glenmark Pharmaceuticals Recent Developments
  • 11.7 Galderma
    • 11.7.1 Galderma Company Details
    • 11.7.2 Galderma Business Overview
    • 11.7.3 Galderma Solid Formulations Drug Delivery Introduction
    • 11.7.4 Galderma Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.7.5 Galderma Recent Developments
  • 11.8 Johnson & Johnson Private
    • 11.8.1 Johnson & Johnson Private Company Details
    • 11.8.2 Johnson & Johnson Private Business Overview
    • 11.8.3 Johnson & Johnson Private Solid Formulations Drug Delivery Introduction
    • 11.8.4 Johnson & Johnson Private Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.8.5 Johnson & Johnson Private Recent Developments
  • 11.9 GlaxoSmithKline
    • 11.9.1 GlaxoSmithKline Company Details
    • 11.9.2 GlaxoSmithKline Business Overview
    • 11.9.3 GlaxoSmithKline Solid Formulations Drug Delivery Introduction
    • 11.9.4 GlaxoSmithKline Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.9.5 GlaxoSmithKline Recent Developments
  • 11.10 Bausch Health Companies
    • 11.10.1 Bausch Health Companies Company Details
    • 11.10.2 Bausch Health Companies Business Overview
    • 11.10.3 Bausch Health Companies Solid Formulations Drug Delivery Introduction
    • 11.10.4 Bausch Health Companies Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.10.5 Bausch Health Companies Recent Developments
  • 11.11 Hisamitsu Pharmaceuticals
    • 11.11.1 Hisamitsu Pharmaceuticals Company Details
    • 11.11.2 Hisamitsu Pharmaceuticals Business Overview
    • 11.11.3 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Introduction
    • 11.11.4 Hisamitsu Pharmaceuticals Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.11.5 Hisamitsu Pharmaceuticals Recent Developments
  • 11.12 Cipla
    • 11.12.1 Cipla Company Details
    • 11.12.2 Cipla Business Overview
    • 11.12.3 Cipla Solid Formulations Drug Delivery Introduction
    • 11.12.4 Cipla Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.12.5 Cipla Recent Developments
  • 11.13 Bayer
    • 11.13.1 Bayer Company Details
    • 11.13.2 Bayer Business Overview
    • 11.13.3 Bayer Solid Formulations Drug Delivery Introduction
    • 11.13.4 Bayer Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.13.5 Bayer Recent Developments
  • 11.14 Viatris
    • 11.14.1 Viatris Company Details
    • 11.14.2 Viatris Business Overview
    • 11.14.3 Viatris Solid Formulations Drug Delivery Introduction
    • 11.14.4 Viatris Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.14.5 Viatris Recent Developments
  • 11.15 3M
    • 11.15.1 3M Company Details
    • 11.15.2 3M Business Overview
    • 11.15.3 3M Solid Formulations Drug Delivery Introduction
    • 11.15.4 3M Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.15.5 3M Recent Developments
  • 11.16 Merck & Co
    • 11.16.1 Merck & Co Company Details
    • 11.16.2 Merck & Co Business Overview
    • 11.16.3 Merck & Co Solid Formulations Drug Delivery Introduction
    • 11.16.4 Merck & Co Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.16.5 Merck & Co Recent Developments
  • 11.17 Crescita Therpeautics
    • 11.17.1 Crescita Therpeautics Company Details
    • 11.17.2 Crescita Therpeautics Business Overview
    • 11.17.3 Crescita Therpeautics Solid Formulations Drug Delivery Introduction
    • 11.17.4 Crescita Therpeautics Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.17.5 Crescita Therpeautics Recent Developments
  • 11.18 Novartis International
    • 11.18.1 Novartis International Company Details
    • 11.18.2 Novartis International Business Overview
    • 11.18.3 Novartis International Solid Formulations Drug Delivery Introduction
    • 11.18.4 Novartis International Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.18.5 Novartis International Recent Developments
  • 11.19 Boehringer Ingelheim
    • 11.19.1 Boehringer Ingelheim Company Details
    • 11.19.2 Boehringer Ingelheim Business Overview
    • 11.19.3 Boehringer Ingelheim Solid Formulations Drug Delivery Introduction
    • 11.19.4 Boehringer Ingelheim Revenue in Solid Formulations Drug Delivery Business (2017-2022)
    • 11.19.5 Boehringer Ingelheim Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer